PHI with Fasciolopsiasis
How does this condition affect your private health insurance?
Fasciolopsiasis is an intestinal infection caused by the giant intestinal fluke, Fasciolopsis buski. Humans contract it by consuming raw aquatic plants, such as water chestnuts or caltrops, contaminated with infective metacercariae. Once ingested, the parasites attach to the small intestine, leading to symptoms like abdominal pain, diarrhea, and nausea. In heavy infections, severe malabsorption, protein-losing enteropathy, edema, ascites, and anemia can occur, particularly in children, potentially causing growth retardation. Diagnosis relies on identifying eggs in stool samples. Praziquantel is the highly effective treatment, generally leading to full recovery. Prevention involves thoroughly cooking aquatic vegetables and improving sanitation.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to months if treated, potentially years if untreated.
Duration of Illness (Lifetime)
One-time event if successfully treated, chronic if untreated or due to repeated re-exposure.
Cost of Treatment (Initial)
Low (e.g., $10-$100 for medication and diagnosis in endemic regions).
Cost of Treatment (Lifetime)
Primarily the initial treatment cost, but higher with complications or repeated infections (e.g., $10-$500).
Mortality Rate
Low (less than 1%) in treated cases, but higher in severe, untreated infections, especially in malnourished children (up to 5%).
Risk of Secondary Damages
Moderate (20-40%) in heavy, untreated infections, leading to malnutrition, anemia, growth retardation, and chronic abdominal issues. Low (<5%) with timely treatment.
Probability of Full Recovery
High (>95%) with appropriate and timely antiparasitic treatment.
Underlying Disease Risk
Moderate (30-60%), as it often co-exists with other parasitic infections (e.g., soil-transmitted helminths) and malnutrition in endemic areas due to shared risk factors like poor sanitation and hygiene.